EU Clinical Trials Regulation (CTR 536/2014)vsTEFCA — Trusted Exchange Framework and Common Agreement
See exactly how EU Clinical Trials Regulation (CTR 536/2014) controls map to TEFCA — Trusted Exchange Framework and Common Agreement. Pre-computed mappings, identified gaps, and coverage analysis.
According to the TheArtOfService Compliance Knowledge Graph:
EU Clinical Trials Regulation (CTR 536/2014) maps to TEFCA — Trusted Exchange Framework and Common Agreement with 24% coverage across 4 directly mapped controls. Analysis of 17 EU Clinical Trials Regulation (CTR 536/2014) controls identifies 13 compliance gaps — primarily concentrated in Chapter III — Subject Protection.
Source: TheArtOfService Knowledge Graph | 17 controls analysed | 693 frameworks | 819K+ cross-framework mappings
Control Mappings
Showing 11 of 11 mapped controls across 2 domains. Sign up to explore all 819K+ mappings across 693 frameworks.
Chapter II — Application and Authorisation(7 mappings)
Chapter VIII-XI — Supervision and Transparency(4 mappings)
Related Comparisons
Other EU Clinical Trials Regulation (CTR 536/2014) comparisons
Other TEFCA — Trusted Exchange Framework and Common Agreement comparisons
Stop Paying Consultants to Read Spreadsheets
AI-powered compliance intelligence across 693 frameworks — at a fraction of consulting costs.
Free
- ✓ 693 framework browser
- ✓ Cross-framework mappings (819K+)
- ✓ 824 compliance assessments
- ✓ 3 AI queries & searches per day
Professional
- ✓ Unlimited AI Compliance Advisory
- ✓ Unlimited full-text search
- ✓ Framework self-assessment
- ✓ PDF, Excel & CSV exports
What are the key differences between EU Clinical Trials Regulation (CTR 536/2014) and TEFCA — Trusted Exchange Framework and Common Agreement?
EU Clinical Trials Regulation (CTR 536/2014) has 17 controls across its framework, while TEFCA — Trusted Exchange Framework and Common Agreement covers 23 controls. Direct mapping analysis identifies 4 overlapping controls (24% coverage). The frameworks diverge most significantly in Chapter III — Subject Protection, where 4 EU Clinical Trials Regulation (CTR 536/2014) controls have no direct TEFCA — Trusted Exchange Framework and Common Agreement equivalent.
How many controls map between EU Clinical Trials Regulation (CTR 536/2014) and TEFCA — Trusted Exchange Framework and Common Agreement?
Of 17 total EU Clinical Trials Regulation (CTR 536/2014) controls, 4 map directly to TEFCA — Trusted Exchange Framework and Common Agreement controls — representing 24% coverage. The remaining 13 controls represent compliance gaps requiring additional documentation or compensating controls to satisfy both frameworks simultaneously.
What are the compliance gaps when mapping EU Clinical Trials Regulation (CTR 536/2014) to TEFCA — Trusted Exchange Framework and Common Agreement?
13 EU Clinical Trials Regulation (CTR 536/2014) controls have no direct equivalent in TEFCA — Trusted Exchange Framework and Common Agreement. The highest concentration of gaps is in Chapter III — Subject Protection with 4 unmapped controls. These gaps represent areas where additional controls, policies, or documentation must be created to achieve compliance with both frameworks.
Which control domains have the most gaps between EU Clinical Trials Regulation (CTR 536/2014) and TEFCA — Trusted Exchange Framework and Common Agreement?
The domain with the highest gap count is Chapter III — Subject Protection (4 gaps). Export the full domain-by-domain gap breakdown via the Professional tier to generate a prioritised remediation roadmap.
Related Resources
This platform provides educational compliance tools, not legal, regulatory, or professional compliance advice. Cross-framework mappings are AI-assisted interpretations and do not reproduce or replace official standards. Framework names and trademarks belong to their respective owners. Consult qualified professionals for your specific compliance requirements. See our Terms of Service.